REH:ASXReece Limited Analysis
Data as of 2026-06-13 - not real-time
A$15.69
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Reece Limited is trading in a bullish technical environment, with price comfortably above the short‑term moving average and a bullish MACD crossover supporting further upside. However, the RSI is well above the typical overbought threshold, and the market price sits far above the discounted cash‑flow implied fair value, suggesting limited upside from a valuation perspective.
Fundamentally, the company delivers modest revenue growth and solid cash generation, but operates on thin margins and carries a notable debt load. The dividend yield is modest yet the payout ratio remains sustainable, and the stock’s low beta points to limited systematic risk. Together, these factors imply a cautiously optimistic stance, favoring a hold in the near term while recognizing longer‑term upside potential if earnings momentum improves.
Fundamentally, the company delivers modest revenue growth and solid cash generation, but operates on thin margins and carries a notable debt load. The dividend yield is modest yet the payout ratio remains sustainable, and the stock’s low beta points to limited systematic risk. Together, these factors imply a cautiously optimistic stance, favoring a hold in the near term while recognizing longer‑term upside potential if earnings momentum improves.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Technical overbought condition (high RSI)
- Price above fair value per DCF
- Increasing volume supporting current level
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Steady cash flow and manageable payout ratio
- Low beta indicating defensive characteristics
- Revenue growth and expansion into multiple geographies
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Resilient industrial distribution sector
- Sustainable dividend and improving leverage profile
- Potential for earnings multiple compression as market re‑prices valuation
Key Metrics & Analysis
Financial Health
Revenue Growth5.60%
Profit Margin3.04%
P/E Ratio35.7
ROE7.22%
ROA4.34%
Debt/Equity64.17
P/B Ratio2.6
Op. Cash FlowA$542.8M
Free Cash FlowA$345.4M
Industry P/E30.6
Technical Analysis
TrendBullish
RSI76.4
SupportA$13.05
ResistanceA$15.96
MA 20A$13.97
MA 50A$13.71
MA 200A$13.02
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Fair ValueA$5.93
Target PriceA$15.19
Upside/Downside-3.16%
GradeOvervalued
TypeBlend
Dividend Yield1.10%
Risk Assessment
Beta0.23
Volatility35.81%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.